1. |
LIU Y C, LIAO C H, CHANG C F, et al. A locallytransmitted case of SARS-CoV-2 infection in Taiwan[J]. New England Journal of Medicine, 2020, 382(11): 1070-1072.
doi: 10.1056/nejmc2001573
|
2. |
HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506.
doi: 10.1016/S0140-6736(20)30183-5
|
3. |
CHEN N S, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.
doi: 10.1016/S0140-6736(20)30211-7
|
4. |
金妍, 王新陆. 山东关于新型冠状病毒肺炎的中医辨证治疗[J]. 山东中医杂志, 2020,39(5):425-428.
doi: 10.16295/j.cnki.0257-358x.2020.05.001
|
5. |
袁成民. 从寒温结合理论探析新型冠状病毒肺炎轻型证治思路[J]. 山东中医杂志, 2020,39(04):320-322.
doi: 10.16295/j.cnki.0257-358x.2020.04.002
|
6. |
RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of Cheminformatics, 2014, 6(1): 1-6.
doi: 10.1186/1758-2946-6-13
|
7. |
GFELLER D, GROSDIDIER A, WIRTH M, et al. Swiss Target Prediction: a web server for target prediction of bioactive small molecules[J]. Nucleic Acids Research, 2014, 42(W1): W32-W38.
doi: 10.1093/nar/gku293
|
8. |
KUMAR S, CHOWDHURY S, KUMAR S. In silico repurposing of antipsychotic drugs for Alzheimer′s disease[J]. BMC Neuroscience, 2017, 18(1): 1-16.
doi: 10.1186/s12868-017-0394-8
|
9. |
FRIESNER R A, MURPHY R B, REPASKY M P, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes[J]. Journal of Medicinal Chemistry, 2006, 49(21): 6177-6196.
doi: 10.1021/jm051256o
|
10 |
KITCHEN D B, DECORNEZ H, FURR J R, et al. Docking and scoring in virtual screening for drug discovery: methods and applications[J]. Nature Reviews Drug Discovery, 2004, 3(11): 935-949.
doi: 10.1038/nrd1549
|
11 |
梁峰, 张涛, 庞稳泰, 等. 基于数据挖掘与“异病同治”探讨中医药治疗新型冠状病毒感染肺炎[J]. 中华中医药学刊, 2020,38(06):5-9.
doi: 10.13193/j.issn.1673-7717.2020.06.002
|
12 |
杨帆, 张伟. 从山东地域特点谈新型冠状病毒肺炎核心病机与诊疗思路[J]. 山东中医杂志, 2020,39(5):429-432.
doi: 10.16295/j.cnki.0257-358x.2020.05.002
|
13 |
田景振, 杨振宁. 中医药抗病毒研究思路、理论创新与基本路径[J]. 山东中医杂志, 2018, 37(6): 439-444.
doi: 10.16295/j.cnki.0257-358x.2018.06.001
|
14 |
ZHOU P, YANG X L, WANG X G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273.
doi: 10.1038/s41586-020-2012-7
|
15 |
WALLS A C, PARK Y J, TORTORICI M A, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein[J]. Cell, 2020,181(2):281-292.
doi: 10.1016/j.cell.2020.02.058
|
16 |
刘昌孝, 王玉丽, 张洪兵, 等. 基于新型冠状病毒感染防控需求,重视中药科学研发与应用[J]. 中草药, 2020,51(6):1361-1374.
doi: 10.7501/j.issn.0253-2670.2020.06.001
|
17 |
JO S, KIM H, KIM S, et al. Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors[J]. Chemical Biology & Drug Design, 2019, 94(6): 2023-2030.
doi: 10.1111/cbdd.13604
|
18 |
JO S, KIM S, SHIN D H, et al. Inhibition of SARS-CoV 3CL protease by flavonoids[J]. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35(1): 145-151.
doi: 10.1080/14756366.2019.1690480
|
19 |
尹明星, 曹艳, 施春阳, 等. 中药防治细胞因子风暴的研究进展[J]. 中草药, 2020, 51(5): 1089-1095.
doi: 10.7501/j.issn.0253-2670.2020.05.001
|
20 |
杜海涛, 孙铁锋, 王平, 等. 呼吸道合胞病毒及其感染相关TLRs的研究进展[J]. 山东科学, 2020, 33(1): 42-50.
doi: 10.3976/j.issn.1002-4026.2020.01.007
|
21 |
BOSCH-BARRERA J, MARTIN-CASTILLO B, BUXO M, et al. Silibinin and SARS-CoV-2: dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 patients[J].Journal of Clinical Medicine, 2020,9(6):1770.
doi: 10.3390/jcm9061770
|
22 |
ALLEGRA A, DI GIOACCHINO M, TONACCI A, et al. Immunopathology of SARS-CoV-2 infection: immune cells and mediators, prognostic factors, and immune-therapeutic implications[J]. International Journal of Molecular Sciences, 2020,21(13):4782.
doi: 10.3390/ijms21134782
|